June 2021 - Page 7 of 17 - NetworkNewsWire

MondayJun 21, 2021 11:14 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Focused on Building Leading U.S. Ecosystem

Recent agreements have been strategic steps taken by BEV to position itself in growing U.S. market Agreements involve key manufacturing, distribution, fulfillment partners TRACE products feature the company’s alkaline, plant-based mineral beverages and nutraceuticals Committed to creating a powerful ecosystem focused on developing and manufacturing alkaline, plant-based, and cannabinoid beverages and supplements, BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has announced a number of agreements recently. Each agreement has been part of a strategic business plan as the company moves into the United States and strengthens its position as a leading resource of high-quality health and wellness beverages and…

MondayJun 21, 2021 9:41 am

Roth Capital Partners’ 7th Annual Virtual London Conference to take place on June 21-23, 2021

The Annual Roth London Conference is set to take place between June 21-23, 2021 The three-day investment forum will feature more than 130 private and public companies Institutional and high-net-worth investors in attendance will have the opportunity to meet with a diverse group of companies in a series of 1-on-1 and small group meetings Roth Capital Partners (“Roth”) is set to host their 7th Annual Roth Virtual London Conference in an entirely virtual setting on June 21-23, 2021. The three-day investment forum will play host to more than 130 private and public companies. Renown for hosting some of the world’s…

MondayJun 21, 2021 9:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gains Inclusion on Russell 2000 Index as Brain Cancer Trial Enrollment Advances

Brain cancer drug developer CNS Pharmaceuticals is actively enrolling patients for a potentially pivotal Phase 2 trial of the company’s lead drug candidate, Berubicin, a promising candidate for treating a devastating condition CNS’s focus has been on developing a means of combating glioblastoma, a fatal, generally incurable class of brain cancers that are aggressive and recurrent amid current surgical and chemotherapy interventions One patient from the Phase 1 trial of Berubicin 15 years ago remains cancer-free, as assessed in November, despite glioblastoma’s reputation for proving fatal generally within about 15 months of diagnosis CNS recently announced it will be included…

FridayJun 18, 2021 2:47 pm

6th Annual Medical Device Human Factors & Usability Conference To Offer Unique Strategies and Effective Design Roadmaps

June 22-24, 2021Virtual Event The 6th Annual Medical Device Human Factors & Usability Conference will be held from June 22-24, 2021, at the Q1 Productions dynamic virtual platform. Companies, representatives, and professionals from the Medical Device, Diagnostic and Combination products industry are invited to attend this virtual event. Operating since 2006, Q1 Productions specializes in delivering educational programming through its curated conferences and research-based events. The programs conducted in Q1 Production conferences are focused and learning is achieved through fun and interactive sessions. The sponsors of the event are: BlackHägen Design is a multidisciplinary, user-research, and product development firm. UserWise…

FridayJun 18, 2021 2:35 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Making Advances in Bladder Cancer Treatment Through Proprietary Imaging Technology

Company’s i/Blue Imaging System(TM) is expected to be completed in 2022 The American Cancer Society estimates that 2021 will see 83,370 new cases of bladder cancer and approximately 17,200 deaths More than half of the patients who underwent a cystoscopy to remove non-muscle-invasive bladder cancer will experience recurrence The bladder cancer market was valued at $3.43 billion in 2020, and is anticipated to reach $4.71 billion by 2028 According to the American Cancer Society, new cases of bladder cancer in the United States are expected to reach 83,730 in 2021 and deaths are anticipated to reach 17,200 (https://nnw.fm/6aZDp). Approximately 50%…

FridayJun 18, 2021 2:23 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reports First Quarter Financials; Anticipates Improved Patient Outcomes with Berubicin

Company expects reporting on interim analysis for the first 18 patients of a Phase 2 multicenter clinical trial of Berubicin in adult GBM patients during the first half of 2022 One patient from the first Berubicin trial has survived cancer-free for 14 years, while two patients saw tumor reduction of up to 80 percent CNS Pharmaceuticals reported a net loss of $3.6 million, attributed to increased personnel, activity preparing for clinical trials, drug manufacturing, and labor for the Phase 2 study The global brain tumor therapeutics market is expected to grow at a CAGR during 2020-2025, resulting in forecasted market…

FridayJun 18, 2021 2:13 pm

Infobird Co., Ltd (NASDAQ: IFBD) Agreements with Zu Li Jian, SaSa Cosmetics, Show Emerging Respect for Its Unique SaaS Solutions

AI solutions company Infobird has announced an agreement to provide e-commerce platform upgrades for elderly consumer footwear manufacturing giant Zu Li Jian The Beijing-based company delivers intelligent B2B services, and the Zu Li Jian agreement demonstrates the growing integration of online consumers among a population more inclined to use traditional market channels Infobird also recently announced an agreement to provide its web-based optimization services to cosmetics retailer SaSa Cosmetics (China) The company has 70 proprietary licensing rights developed under its cloud computing structure and AI technologies, and recently completed its launch on the Nasdaq Capital Market A month after SaaS…

FridayJun 18, 2021 1:49 pm

RYAH Group Inc. (CSE: RYAH) Completes First Shipment of SMART Inhalers to UK Clinical Trial

The first shipment of SMART inhalers, 10,000 cartridges and QR codes arrived in the UK for the clinic's pilot run Due to the large scale of the clinical trial, RYAH developed a custom software solution for the clinic In the UK the medical cannabis market is expected to reach $1.3 billion by 2024, and 1% of the population could be medical cannabis patients by 2028 RYAH Group (CSE: RYAH), a connected device and big data and technology company, has completed its initial shipment to a major international clinic conducting a study in the UK on the safety and efficacy of…

FridayJun 18, 2021 1:36 pm

DSG Global Inc. (DSGT) Receives Contracts Totaling $987,900 from New Golf Courses in US, Singapore

DSGT selected as fleet-management solution provider for new golf courses. Contracts include servicing and maintenance fees, which provide ongoing continuous monthly revenue. CEO reports continued sales records, progress in Vantage Tag and Imperium Motors divisions. DSG Global (OTCQB: DSGT), an emerging global technology company with an array of interconnecting businesses in some of the fastest-growing market sectors, and its Vantage Tag System (“VTS”) have been selected as the fleet-management solution provider for 15 new golf courses (https://nnw.fm/MpiCM). The contracts for the courses, which are located in the United States and abroad, total almost $988,000 and provide an ongoing revenue stream…

FridayJun 18, 2021 10:27 am

HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Gains 10 SKU Private Label Deal with Leading Grocery Retailer, Positioned to Benefit from CBD, Probiotic Global Markets

“Private Label” division will be the sixth distribution channel for HempFusion and its family of products The 10 SKU deal totals approximately $250,000 and is expected to double in revenue size in 2021 and quadruple in 2022 Company will be expanding its Topeka, Kansas facility to accommodate orders of this magnitude, requiring additional equipment and human capital Research and development teams are currently working with an additional 30 products under development for the HempFusion and family of brands HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) recently announced that a leading national and publicly traded grocery retailer has awarded the…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: June 2021